poisar

Stock

SNSE SNSE

$13.91+7.00%

Overview

SNSE market data

Price History

SNSE price chart · 1M
O
15.07
H
15.94
L
13.89
C
13.91
Vol
3,440.00
Source
US equities market feed
Observed
Jun 15, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$15.07
Previous Close
$13.00
Day High
$15.94
Day Low
$13.89
52 Week High
$30.50
52 Week Low
$10.91
7 Day Return
+6.51%
30 Day Return
-29.73%
90 Day Return
-49.67%
1 Year Return
-49.67%
Daily Notional Volume
$47.9K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$16.72
Diluted earnings per share over the trailing twelve months.
Beta
-0.30
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$7.45 – $37.90
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $19.5M · P/B 0.72.

Company News

10 captured
8-K filing — Faeth Therapeutics, Inc. (SNSE)SEC EDGAR · Jun 18, 2026, 9:13 PM
BTIG Reiterates Buy on Sensei Biotherapeutics, Maintains $55 Price TargetBenzinga · Jun 15, 2026, 5:10 PM
Sensei Biotherapeutics Changes Corporate Name To Faeth Therapeutics, Ticker To FTH, Effective June 16; Appoints Anand Parikh Chairman, President And CEO; Brian Stephenson Appointed CFO, Effective June 12Benzinga · Jun 15, 2026, 12:20 PM
8-K filing — Sensei Biotherapeutics, Inc. (SNSE)SEC EDGAR · Jun 15, 2026, 12:16 PM
Sensei Biotherapeutics shares are trading higher after BTIG initiated coverage on the stock with a Buy rating and announced a $55 price target.Benzinga · Jun 11, 2026, 5:09 PM
This MarketAxess Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For ThursdayBenzinga · Jun 11, 2026, 3:42 PM
This Henry Schein Analyst Turns Bullish; Here Are Top 5 Upgrades For ThursdayBenzinga · Jun 11, 2026, 12:05 PM
This Daktronics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For ThursdayBenzinga · Jun 11, 2026, 11:17 AM
BTIG Initiates Coverage On Sensei Biotherapeutics with Buy Rating, Announces Price Target of $55Benzinga · Jun 11, 2026, 10:15 AM
Cantor Fitzgerald Initiates Coverage On Sensei Biotherapeutics with Overweight RatingBenzinga · May 29, 2026, 2:45 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock